Evidence map›Paper›PMID 35430053›Full record

ArticleJournal of the American Academy of Dermatology2022

Response to "Comments on sirolimus use and risk of cutaneous squamous cell carcinoma (SCC) in solid organ transplant recipients" (SOTRs).

Maryam M Asgari, Sarah Arron, E Margaret Warton, Charles P Quesenberry, Dana Weisshaar

Open access · greenAbstract readLetterComment
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of the American Academy of Dermatology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 95% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Maryam M AsgariDepartment of Dermatology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts; Division of Research, Kaiser Permanente Northern California, Oakland, California. Electronic address: harvardskinstudies@partners.org.
Sarah ArronDepartment of Dermatology, University of California at San Francisco, San Francisco, California.
E Margaret WartonDivision of Research, Kaiser Permanente Northern California, Oakland, California.
Charles P QuesenberryDivision of Research, Kaiser Permanente Northern California, Oakland, California.
Dana WeisshaarDepartment of Cardiology, Santa Clara, Kaiser Permanente Northern California, Santa Clara, California.
Kaiser Permanente · USKaiser Permanente Santa Clara Medical Center · USUniversity of California, San Francisco · US

Funding

Patient-oriented research and mentoring program in dermatologic diseasesK24AR069760 · NIAMS · UNIVERSITY OF COLORADO DENVER · PI ASGARI, MARYAM MANDANA · 2017 to 2025
$1.9M
PQ3 Cutaneous squamous cell carcinoma: Integrating germline and somatic alterations that underlie tumor progressionR01CA231264 · NCI · UNIVERSITY OF COLORADO DENVER · PI ASGARI, MARYAM MANDANA · 2019 to 2023
$1.5M
Genome-wide association study of cutaneous squamous cell carincomaR01CA166672 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI ASGARI, MARYAM MANDANA · 2013 to 2016
$1.3M
NCI NIH HHS R01 CA166672NCI NIH HHS R01 CA231264NIAMS NIH HHS K24 AR069760
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID35430053
PMCPMC9904155
OpenAlexW4223944511

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.